rss-es – Página 54

Do Not Use Infant Head Shaping Pillows to Prevent or Treat Any Medical Condition: FDA Safety Communication

Murilo Freitas - 04:00, 2 de noviembre de 2022479

The FDA recommends that parents, caregivers, and health care providers not to use infant head shaping pillows to prevent or treat any medical condition.

http://www.fda.gov/medical-devices/safety-communications/do-not-use-infant-head-shaping-pillows-prevent-or-treat-any-medical-condition-fda-safety

rss-es

FDA Infant Formula Update: November 2, 2022

Murilo Freitas - 19:17, 1 de noviembre de 2022408

FDA Infant Formula Update: November 2, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-november-2-2022

rss-es

Teleflex Recalls Iso-Gard Filter S for Risk of Splitting or Detaching That May Cause Leakage and Insufficient Air Supply to Patients

Murilo Freitas - 04:00, 1 de noviembre de 2022392

The Iso-Gard Filter S is a breathing circuit bacterial filter. It may split or detach preventing patients from getting sufficient supply of air.

http://www.fda.gov/medical-devices/medical-device-recalls/teleflex-recalls-iso-gard-filter-s-risk-splitting-or-detaching-may-cause-leakage-and-insufficient

rss-es

FDA Roundup: November 1, 2022

Murilo Freitas - 20:55, 31 de octubre de 2022300

FDA Roundup: November 1, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-1-2022

rss-es

Reuse Tracheostomy Tubes or Switch to Appropriate Alternatives During Shortage: FDA Safety Communication

Murilo Freitas - 04:00, 30 de octubre de 2022416

The FDA recommends using the following strategies to reduce the number of tracheostomy tubes used per patient during the shortage.

http://www.fda.gov/medical-devices/safety-communications/reuse-tracheostomy-tubes-or-switch-appropriate-alternatives-during-shortage-fda-safety-communication

rss-es

Consider Alternatives for MRI-Guided Breast Biopsy Grid Plates Due to Shortage – Letter to Health Care Providers

Murilo Freitas - 04:00, 30 de octubre de 2022436

The FDA recommends health care providers discuss alternatives for MRI-guided breast biopsies with patients due to shortage of Philips Invivo plates and disposables.

http://www.fda.gov/medical-devices/letters-health-care-providers/consider-alternatives-mri-guided-breast-biopsy-grid-plates-due-shortage-letter-health-care-providers

rss-es

FDA Roundup: October 28, 2022

Murilo Freitas - 20:27, 27 de octubre de 2022388

FDA Roundup: October 28, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-28-2022

rss-es

FDA Denies Marketing of Logic’s Menthol E-Cigarette Products Following Determination They Do Not Meet Public Health Standard

Murilo Freitas - 16:27, 25 de octubre de 2022375

FDA Denies Marketing of Logic’s Menthol E-Cigarette Products Following Determination They Do Not Meet Public Health Standard
http://www.fda.gov/news-events/press-announcements/fda-denies-marketing-logics-menthol-e-cigarette-products-following-determination-they-do-not-meet

rss-es

FDA Roundup: October 25, 2022

Murilo Freitas - 20:47, 24 de octubre de 2022397

FDA Roundup: October 25, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-25-2022

rss-es

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Recall of Two (2) Lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, Due to the Detection of N-Nitroso Quinapril Impurity

Murilo Freitas - 04:00, 24 de octubre de 2022382

East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 12.5mg, to the consumer level from the US market due to presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aurobindo-pharma-usa-inc-initiates-voluntary-nationwide-recall-two-2-lots-quinapril-and